
Rabca IV Injection
Marketer
H & Care Incorp
Salt Composition
Rabeprazole (20mg)
Overview Rabca IV Injection
Injex, an intravenous medication, neutralizes stomach acid. It treats acid-related gastrointestinal disorders like reflux, indigestion, peptic ulcers, and other hyperacidity conditions. Providing rapid symptom relief, Injex is also prophylactic against stress ulcers in critically ill patients and pre-anesthesia to minimize aspiration risks. A proton pump inhibitor (PPI), Injex is administered intravenously by a healthcare provider when oral medication is unsuitable. Dosage and treatment duration are determined by your physician based on individual needs and response. Optimal results are achieved by following the prescribed regimen, adopting smaller, more frequent meals, and avoiding caffeine, spicy, and fatty foods. Common, generally mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects require medical attention. Prolonged use, particularly exceeding one year or with higher doses, elevates the fracture risk; discuss bone health strategies, including calcium and vitamin D supplementation, with your doctor. Hypomagnesemia (low magnesium) can occur after three months of use, manifesting as fatigue, confusion, dizziness, muscle spasms, or irregular heartbeat. Your physician may monitor your magnesium levels. Injex is contraindicated in individuals with severe hepatic impairment, those on HIV medications, those with a history of PPI allergy, or pre-existing osteoporosis. Pregnant or breastfeeding individuals should consult their doctor. Alcohol should be avoided due to its acid-stimulating effects. Refrain from operating machinery if dizziness or drowsiness occurs.
Primary Ingredients of Rabca IV Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Rabca IV Injection
Management of acid indigestion and peptic ulcers
Major Benefits of Rabca IV Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Rabca IV Injection:
- Nausea
- Vomiting
- Headache
- Dizziness
- Flatulence
- Diarrhea
- Stomach pain
- Thrombophlebitis
How to use Rabca IV Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Rabca IV Injection works:
Rabca IV Injection, a proton pump inhibitor, decreases stomach acid production, thus alleviating acid indigestion and heartburn symptoms.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using alcohol concurrently with Rabca IV Injection. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Rabca IV Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administration of Rabca IV Injection while breastfeeding may pose a risk. Available evidence from human studies indicates potential transfer of the medication into breast milk, possibly causing harm to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Rabca IV Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Rabca IV Injection poses no known safety concerns for patients with renal impairment and requires no dosage modification.
LiverCAUTION
Administering Rabca IV Injection requires careful consideration in individuals with advanced hepatic impairment. Dosage modification for Rabca IV Injection might be necessary. Physician consultation is advised.
What if you forget to take Rabca IV Injection :
Should you forget a scheduled Rabca IV Injection, seek medical advice from your physician.
Facts to Know About Rabca IV Injection
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Digestive System |
| Behavior Class | Gastric acid suppressants |
